The Italian Tamoxifen Prevention Trial

Dis Markers. 1999 Oct;15(1-3):199-200. doi: 10.1155/1999/836912.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Anticarcinogenic Agents / adverse effects
  • Anticarcinogenic Agents / therapeutic use*
  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / prevention & control*
  • Cohort Studies
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Hormone Replacement Therapy
  • Humans
  • Hypertriglyceridemia / chemically induced
  • Hysterectomy
  • Italy / epidemiology
  • Middle Aged
  • Ovariectomy
  • Risk
  • Tamoxifen / adverse effects
  • Tamoxifen / therapeutic use*
  • Thromboembolism / chemically induced

Substances

  • Anticarcinogenic Agents
  • Antineoplastic Agents, Hormonal
  • Tamoxifen